Dr. Rajat Saha

Medical Degrees:

• MBBS: Grant Medical College, Mumbai
• MD Medicine: Grant Medical College, Mumbai
• DNB Medical Oncology: Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC), Delhi

Certifications & Accreditations:

• • Certified Member, European Society of Medical Oncology (ESMO)

Major Cancer Types Treated:

• Head and Neck Cancers
• Brain Tumours
• Breast Cancer
• Geriatric Oncology

Sub-specialties:

• Medical Oncology
• Head & Neck Oncology
• Neuro-Oncology
• Breast Oncology
• Geriatric Oncology

Advanced Procedures Performed:

• • Advanced Chemotherapy Regimens
  • Targeted Therapy
  • Immunotherapy
  • Hormonal Therapy
  • Clinical management of complex cancer cases

Current & Past Hospital Affiliations:

• Current Affiliations: Senior Consultant & Unit Head, Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC), Delhi
• Past Affiliations:
  • Associate Director, Medical Oncology at Max Superspeciality Hospital, Patparganj & Vaishali (2016 – 2023)
  • Senior Consultant, Medical Oncology at Max Superspeciality Hospital, Delhi (2014 – 2016)
  • Consultant in Medical Oncology at BLK Superspeciality Hospital, Delhi (2011 – 2014)
  • Consultant in Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC), Delhi (2011 – 2011)
  • DNB residency program in Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC), Delhi (2008 – 2011)
  • Senior Resident in Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC), Delhi (2007 – 2008)
  • Senior Resident in Nephrology, Sir J.J Group of Hospitals, Mumbai (2006 – 2006)
  • MD Medicine program, Grant Medical College and Sir J.J. Group of Hospitals (2003 – 2006)
  • Junior Resident in Medicine, GTB Hospital, Delhi (2002 – 2002)

Academic & Research Roles:

• Credited with imparting knowledge to Oncology students across India.

Key Achievements & Contributions:

• National oncology quiz master, having organised regional and national level oncology quizzes.
• Co-investigator in an international multicentre trial of Sativex, a transmucosal cannabinoid spray for the control of cancer-related pain.
• Co-investigator in a Novartis-sponsored multicentre trial of Buparlisib, an oral PI3K inhibitor in recurrent head and neck cancers.

Published Papers in Medical Journals:

• "Chemotherapy-Induced Palmoplantar Erythrodysesthesia in a Child with Burkitt Lymphoma," Pediatric Blood & Cancer (2009)
• "Mediastinal Gray zone lymphoma," The Indian Journal of Chest Diseases & Allied Sciences (2015)

Books & Chapters Authored:

• Chapter titled ‘CML- Overview and Recent Advances’ in APICON yearbook (2010)
• Chapter titled ‘Targeted therapy in Lung Cancer’ in Lung Cancer year book (2012)

Ongoing Clinical Trials Participation:

• Co-investigator in international multicentre trial of Sativex.
• Co-investigator in Novartis sponsored multicentre trial of Buparlisib.

Notable Cases Handled:

• Dr. Saha has successfully treated numerous patients with complex head and neck, neuro, and breast cancers, employing advanced medical oncology protocols. His participation in international clinical trials reflects his commitment to bringing cutting-edge treatments to his patients.

Patient Testimonials:“Dr. Rajat Saha provided exceptional care for my mother’s breast cancer. His empathetic approach and thorough explanation of the treatment plan gave us immense confidence. We truly felt supported throughout her journey.” – Priya S.“As a leading medical oncologist, Dr. Rajat Saha’s expertise in head and neck cancer is outstanding. He combines vast knowledge with genuine compassion, making a daunting diagnosis manageable. I am very thankful for his guidance.” – Anil K.“I highly recommend Dr. Rajat Saha for anyone seeking a top oncologist in Delhi. His holistic approach to my neuro-oncology treatment, focusing not just on medication but also lifestyle, made a significant difference to my recovery and well-being.” – Sarah K.

Patient-Centred Care: Dr. Rajat Saha's philosophy centres on the belief that holistic treatment of cancer begins with prevention and lifestyle modifications. He is a compassionate medical oncologist who prioritises individualised patient care, ensuring that each patient's unique needs and circumstances are considered in their treatment plan. He believes in fostering strong patient-doctor relationships based on trust and clear communication.Technology & Innovation: Dr. Saha is a proactive participant in collaborative research, particularly in international multicentre trials, which allows him to integrate the latest advancements in targeted therapy and new drug developments into his practice. His interest in Head and Neck Oncology, Neuro-Oncology, and Breast Oncology keeps him at the forefront of innovative cancer treatments.

Treatment Type	Cost in INR (Approx.)	Cost in USD (Approx.)
Head & Neck Cancer Chemotherapy	4,00,000 - 12,00,000	4,800 - 14,500
Breast Cancer Chemotherapy	3,50,000 - 10,00,000	4,200 - 12,000
Neuro-Oncology Chemotherapy	5,00,000 - 15,00,000	6,000 - 18,000
Targeted Therapy for Cancer	6,00,000 - 20,00,000	7,200 - 24,000
Immunotherapy for Cancer	8,00,000 - 25,00,000	9,600 - 30,000
Geriatric Oncology Consultation	2,000 - 5,000	25 - 60

Note: These are estimates. For appointment booking and to get a personalised cost estimate, you can connect with the Cancer Rounds team.

Language Support: The Cancer Rounds team typically offers support for international patients, including language services to ensure clear communication throughout the treatment journey.Visa & Travel Assistance: The Cancer Rounds team assists with visa processes, travel arrangements, airport transfers, and accommodation, making the experience seamless for international patients visiting Delhi.Pre-treatment Virtual Consultations: Telemedicine capabilities may be available for initial discussions, review of medical records, and second opinions before international patients travel, facilitating a smooth transition to treatment.